No results for ‘’
Ajanta Pharma Ltd
₹3563.60
(1.80%)
Mon, 28 Sept 2026, 00:35 am
Health Technology
Pharmaceuticals: Major
24.5KAjanta Pharma Enterprise Value (EV)
| Particulars | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 7.02 | 5.74 | 4.28 | 2.36 | 6.27 | 4.62 | 6.93 | 13.47 | 15.08 | 34.81 | 29.86 | 30.57 | 26.40 | 23.44 | 25.49 | 23.88 | 21.94 | 26.34 | 34.55 | 35.61 |
| Price to book ratio | 0.80 | 0.73 | 0.70 | 0.38 | 1.15 | 1.02 | 1.79 | 3.83 | 5.93 | 12.81 | 10.42 | 9.88 | 6.06 | 4 | 4.59 | 5.18 | 4.73 | 4.49 | 7.90 | 8.63 |
| Price to sales ratio | 0.38 | 0.33 | 0.30 | 0.17 | 0.52 | 0.46 | 0.80 | 1.64 | 2.99 | 7.42 | 7.24 | 8.09 | 6.01 | 4.50 | 4.65 | 5.49 | 4.74 | 4.16 | 6.74 | 7.10 |
| Price to cash flow ratio | 6.51 | 9.62 | 31.13 | 5.47 | 2.84 | 2.84 | 10.14 | 6.98 | 16.75 | 38.57 | 37.41 | 25.45 | 43.41 | 23.98 | 26.29 | 27.40 | 28.15 | 19.61 | 34.88 | 27.68 |
| Enterprise value | 179Cr | 193Cr | 262Cr | 302Cr | 426Cr | 410Cr | 723Cr | 1589Cr | 3541Cr | 10703Cr | 12374Cr | 15245Cr | 12100Cr | 8940Cr | 11725Cr | 15262Cr | 15330Cr | 14684Cr | 27776Cr | 32210Cr |
| Enterprise value to EBITDA ratio | 5.27 | 4.86 | 5.09 | 4.71 | 5.52 | 4.25 | 5.32 | 7.42 | 10.46 | 22.41 | 20.61 | 22.80 | 19.74 | 16.32 | 16.86 | 15.58 | 16.91 | 17.45 | 23.57 | 25.55 |
| Debt to equity ratio | 0.91 | 1.01 | 1.29 | 1.59 | 1.23 | 0.83 | 0.67 | 0.32 | 0.22 | 0.09 | 0.07 | 0 | 0 | 0.02 | 0.03 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Return on equity % | 0 | 13.11 | 17.49 | 17.42 | 19.88 | 24.51 | 29.33 | 32.43 | 47.40 | 43.20 | 40.91 | 36.75 | 25.97 | 18.05 | 19.31 | 23.38 | 22.77 | 17.68 | 23.47 | 25.02 |
Ajanta Pharma Ltd Enterprise Value
The Ajanta Pharma Ltd Enterprise Value is a key financial metric used by investors to evaluate Ajanta Pharma Ltd's valuation, profitability, and overall financial performance. Tracking the Ajanta Pharma Ltd Enterprise Value helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Ajanta Pharma Ltd (NSE: AJANTPHARM, BSE: 532331) is currently trading at ₹3563.60, with a market capitalization of ₹44562.26Cr. As a leading company in the Health technology sector and Pharmaceuticals: major industry, monitoring the Ajanta Pharma Ltd Enterprise Value is essential for fundamental analysis.
Ajanta Pharma Ltd Enterprise Value Current Value
The current Ajanta Pharma Ltd Enterprise Value stands at 32210Cr.
The latest Ajanta Pharma Ltd Enterprise Value has increased compared to the previous period, indicating rising valuation or improved investor sentiment.
Ajanta Pharma Ltd Enterprise Value Historical Trend
The Ajanta Pharma Ltd Enterprise Value has shown the following historical trend:
- 2024: 32210Cr
- 2023: 27776Cr
- 2022: 14684Cr
- 2021: 15330Cr
- 2020: 15262Cr
The recent rise in Ajanta Pharma Ltd Enterprise Value suggests strengthening valuation trends and improving market sentiment.
What Ajanta Pharma Ltd Enterprise Value Indicates for Investors
The Ajanta Pharma Ltd Enterprise Value plays a crucial role in understanding the company's financial health and valuation.
This ratio is an important metric used in fundamental analysis of Ajanta Pharma Ltd.
Ajanta Pharma Ltd Enterprise Value Analysis Summary
The Ajanta Pharma Ltd Enterprise Value remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Ajanta Pharma Ltd Enterprise Value should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Ajanta Pharma Ltd Enterprise Value helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.